Fusen Pharmaceutical Co., Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: KYG370981030

HKD

1.26

0.89 (236.0%)

Apr 02

HKG

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Golden Throat Holdings Group Co., Ltd.

Dawnrays Pharmaceutical Holdings Ltd.

TOT BIOPHARM International Co. Ltd.

Shanghai Henlius Biotech, Inc.

Charmacy Pharmaceutical Co., Ltd.

Hua Medicine Ltd.

Immunotech Biopharm Ltd.

Transcenta Holding Ltd.

Abbisko Cayman Ltd.

Zhaoke Ophthalmology Ltd.

Fusen Pharmaceutical Co., Ltd.

Why is Fusen Pharmaceutical Co., Ltd. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Fusen Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Fusen Pharmaceutical Co., Ltd.

-100.0%

0.02

386.44%

Hang Seng Hong Kong

8.99%

0.36

24.71%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-12.52%

EBIT Growth (5y)

-206.03%

EBIT to Interest (avg)

3.07

Debt to EBITDA (avg)

2.34

Net Debt to Equity (avg)

1.06

Sales to Capital Employed (avg)

0.51

Tax Ratio

1.90%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

5.65%

ROE (avg)

3.42%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.64

EV to EBIT

-7.26

EV to EBITDA

-14.27

EV to Capital Employed

0.82

EV to Sales

1.89

PEG Ratio

Dividend Yield

ROCE (Latest)

-11.36%

ROE (Latest)

-52.05%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

NET PROFIT(HY)

Higher at HKD -24.85 MM

-6What is not working for the Company

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.89 times

NET SALES(Q)

Lowest at HKD 119.54 MM

RAW MATERIAL COST(Y)

Grown by 31.56% (YoY

Here's what is working for Fusen Pharmaceutical Co., Ltd.

Net Profit

Higher at HKD -24.85 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Depreciation

Highest at HKD 25.31 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 25.31 MM has Grown at 11.72%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Fusen Pharmaceutical Co., Ltd.

Net Sales

Lowest at HKD 119.54 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term sales trend is very negative

Net Sales (HKD MM)

Debtors Turnover Ratio

Lowest at 0.89 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Net Sales

Fallen at -43.81%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (HKD MM)

Raw Material Cost

Grown by 31.56% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales